Dimplex is a manufacturer of heaters supplied throughout the UK and beyond. The range of heaters within the Dimplex brand is numerous and includes electric panel heaters, storage heaters and tubular heaters among others too. There are a good number of reasons to consider purchasing a heater from the Dimplex range and this article will tell you why. Once you have all the facts about Dimplex then you are sure to want to find a brochure and start choosing the heating for your home right away.
The Phase I clinical trial is designed as an open-label, dose escalation study in which a total of approximately 15-25 human papillomavirus negative (HPV-) locally advanced head and neck cancer patients will be treated with CUDC-101 in combination with cisplatin and radiation at four study centers in the United States. The primary objective of this study is to establish the safety, tolerability and maximum tolerated dose (MTD) of CUDC-101 in this patient population. Secondary objectives are to (i) evaluate the efficacy of CUDC-101, cisplatin and radiation therapy combination, (ii) assess the pharmacokinetics of CUDC-101, and (iii) evaluate tumor markers for response associated with CUDC-101, cisplatin and radiation activity. CUDC-101 will be administered three times per week for 8 consecutive weeks, with a beginning dose of 225 milligrams per meter2. The MTD of CUDC-101 in a previously completed single agent Phase I clinical trial was established as 275 milligrams per meter2.St. Vincent's Medical Center (SVMC), founded by the Daughters of Charity in 1916, is a 528-bed comprehensive, acute care hospital. It is part of St. Vincent's HealthCare and Ascension Health, the largest non-profit health system in the United States, as well as the largest Catholic hospital system in the country. SVMC is widely recognized for excellence in patient care and has received numerous accolades from Health Grades as well as US News and World Report.About the Phase I Combination TrialThe safety profile observed to-date for both dosing schedules appears to be generally consistent with that observed in the Phase I dose escalation study, in which the most frequent adverse events observed were mild to moderate and included fatigue, vomiting, dyspnea (shortness of breath), pyrexia (fever), and dry skin. In addition, stable disease was observed in several patients in this study. Most notably, stable disease was observed in four patients with advanced liver cancer. Two of these patients have been treated with CUDC-101 for over six months, with one patient remaining on study after 11 months. We have also observed ongoing stable disease of greater than 10 months in an advanced breast cancer patient.Curis has completed a Phase I dose escalation clinical trial of CUDC-101 in 25 patients with advanced, refractory solid tumors and has also enrolled 45 of 50 patients in an ongoing Phase I expansion trial to test CUDC-101 in patients with specific tumor types, including breast, gastric, head and neck, liver and non-small cell lung cancers. The Phase I expansion trial is designed as an open-label study in which patients are treated with CUDC-101 at the MTD of 275 milligrams per meter2. The primary objectives of this study are to compare the safety and tolerability of CUDC-101 in subjects with these specific advanced solid tumors when the drug is administered either on a five days per week schedule (one week on/one week off) or on a three days per week schedule (three weeks on/one week off).Gamma Knife Perfexion maintains full clinical compatibility with the classic Gamma Knife and is supported by efficacy and outcome data from 600,000 treated patients worldwide and thousands of peer-reviewed scientific articles, making it a proven choice for radiosurgery of the brain. According to its manufacturer, Elekta, Gamma Knife Perfexion reduces unwanted body dose to the patient by up to 100 times compared with competing technologies, which is particularly important for treatment of children and women of childbearing age, and allows for a dramatically increased treatable volume, which is expected to increase the number of patients that can benefit from Gamma Knife surgery. Elekta estimates that the fully automated and efficient single push-button approach can save 3-5 working weeks of physician time per year at an average Gamma Knife center.
If you are looking for heaters for the home then you can�t go wrong with dimplex heaters. There are a range of heaters to choose from including storage heaters, panel heaters, tubular heaters and more. Visit your nearest electrical wholesaler to find a good selection of heaters to choose from and start saving money on your heating bills and fuel costs today.
Author: Kathryn Dawson
No comments:
Post a Comment